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Cyclic diguanylate (c-di-GMP) is an allosteric activator and
second messenger implicated in the regulation of a variety of
biological processes in diverse bacteria. InVibrio cholerae, c-di-
GMP has been shown to inversely regulate biofilm-specific and
virulence gene expression, suggesting that c-di-GMP signaling
is important for the transition of V. cholerae from the environ-
ment to the host. However, the mechanism behind this regula-
tion remains unknown. Recently, it was proposed that the PilZ
protein domain represents a c-di-GMP-binding domain. Here
we show that V. cholerae PilZ proteins bind c-di-GMP specifi-
cally and are involved in the regulation of biofilm formation,
motility, and virulence. These findings confirm a role for PilZ
proteins as c-di-GMP-sensing proteins within the c-di-GMP
signaling network.
Bis(3,5)-cyclic diguanylic acid (c-di-GMP)3 is a cyclic dinu-
cleotide that has recently been recognized as an important
intracellular signaling molecule in diverse bacteria. c-di-GMP
was originally identified inGluconacetobacter xylinus (formerly
Acetobacter xylinum) as a positive allosteric regulator of cel-
lulose synthase (1–3). Since its discovery almost 20 years
ago, c-di-GMP has been implicated in regulation of a variety
of biological processes, including production of extracellular
polysaccharide matrices in Salmonella enterica serovar
Typhimurium, Pseudomonas aeruginosa, Yersinia pestis,
and Vibrio cholerae (4–7); motility in S. enterica Typhi-
murium, P. aeruginosa, Escherichia coli, and Caulobacter
crescentus (7, 9–11); and virulence in S. enterica Typhi-
murium and V. cholerae (12, 13).
The intracellular concentration of c-di-GMP is regulated by
the opposing activities of diguanylate cyclase (DGC) and phos-
phodiesterase A (PDEA) enzymes (14, 15). DGCs catalyze for-
mation of c-di-GMP through the 3 to 5 linkage of two GTP
molecules into a cyclic molecule releasing two pyrophosphate
molecules. Some DGCs contain a feedback-inhibitory site
(I-site) that binds dimeric c-di-GMP (16), and thus the I-site
comprises one type of c-di-GMP binding domain. PDEAs bind
c-di-GMP and degrade it via linearization to pGpG; the linear
intermediate is further hydrolyzed to two GMPmolecules by a
second, presumably ubiquitous phosphodiesterase B (16, 17).
Thus, PDEAsmust also contain a c-di-GMPbinding site, although
this site has yet to be defined. The DGC and PDEA activities
have been attributed to proteins containing GGDEF and EAL
domains, respectively, each named for conserved amino acid
residues (17–22). In addition, the HD-GYP domain proteins
have recently been shown to degrade c-di-GMP (23).
In V. cholerae, the causative agent of cholera, c-di-GMP is
thought to play a role inmediating the transition from environ-
mental reservoirs to the human host. This bacterium normally
inhabits temperate waters around the world, including salt,
brackish, and some fresh waters (24). Upon entry into a human
host via ingestion of contaminated food or water, the bacteria
pass through the gastric acid barrier of the stomach and colo-
nize the small intestine. As the bacterium transitions from its
natural environment to that of the small intestine, it undergoes
a shift from environmental to virulence gene expression (25–
29). Depending on the environmental niche, these changesmay
include a decrease in transcription ofVibrio exopolysaccharide
synthesis (vps) genes required for biofilm formation (30). In all
cases, however, entry into the small intestine is believed to
induce the expression of virulence factors, including the toxin
co-regulated pilus, required for colonization of the small intes-
tine, and cholera toxin (CT), the factor responsible for profuse
secretory diarrhea (29, 31). It has been shown that c-di-GMP
inversely regulates transcription of vps and virulence genes in
V. cholerae, where a high level of c-di-GMP favors expression of
vps genes and repression of CT expression, and vice versa for a
low level of c-di-GMP (8, 13).
There is evidence that V. cholerae forms biofilms on sur-
faces such as the chitinous exoskeleton of zooplankton and
phytoplankton, suggesting that intracellular c-di-GMP lev-
els may be high in V. cholerae inhabiting environmental res-
ervoirs (32–34). In the classical biotype of V. cholerae, it has
been shown that expression of the PDEA VieA positively
regulates virulence gene expression and negatively regulates
vps expression (8, 13, 17). This information supports the
model that c-di-GMP assists in the transition from environ-
ment to host via modulation of gene expression. However, the
mechanism(s) underlying c-di-GMP-mediated regulation,
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including how changes in c-di-GMP concentration within the
cell are sensed, remain unknown.
Recently, Amikam and Galperin (35) reported the in silico
identification of a putative c-di-GMP-binding protein domain,
PilZ (Pfam domain PF07238) (36), which is distinct from the
DGC I-site and PDEA c-di-GMP binding domains. Evidence in
support of this claim is as follows. 1) Three proteins known to
bind c-di-GMP contain a PilZ domain, including cellulose syn-
thase from G. xylinus, YcgR from E. coli, and PA4608 from P.
aeruginosa (3, 37, 38, 39, 40). 2) Several PilZ-containing pro-
teins have been characterized by mutational analysis and
appear to regulate phenotypes associated with c-di-GMP-me-
diated signaling pathways. 3) The phyletic distribution of PilZ
domains generally parallels those of the GGDEF and EAL
domains, including an absolute correlation between PilZ,
GGDEF, and EAL domains in the -proteobacteria family, of
which V. cholerae is a member. Recently, the binding of E. coli
YcgR to c-di-GMP was confirmed by mutational analysis, and
this protein was shown to regulate motility in a c-di-GMP-de-
pendent manner (39).
There are five PilZ coding sequences in the V. cholerae
genome, (VC0697, VC1885, VC2344, VCA0042, and VCA0735),
each having unknown function.Wehave designated these plzA,
plzB, plzC, plzD, and plzE, respectively. Here, we provide evi-
dence in support of the hypothesis that PilZ acts as a c-di-GMP-
binding domain and regulator of downstream processes. We
show that PilZ proteins specifically bind c-di-GMP in vitro.
Moreover, deletion of a subset of PilZ genes results in changes
in biofilm formation, motility, and colonization of the small
intestine in an animal model of infection, consistent with their
role in the c-di-GMP regulatory network.
EXPERIMENTAL PROCEDURES
Growth Conditions—Bacteria were grown in Luria-Bertani
(LB) broth at 37 °C with aeration unless otherwise noted. M9
minimal medium supplemented with 0.5% glycerol, trace met-
als (1 ml/liter 5% MgSO4, 0.5% MnCl24H2O, 0.5% FeCl3, 0.4%
trinitriloacetic acid) (41), and 25 mM each of L-Asn, L-Arg,
L-Glu, and L-Ser (M9  NRES) was prepared as previously
described (42). Expression from the ParaBAD promoter was
induced by the addition of L-arabinose to a final concentration
of 0.1%. Expression from the Ptac promoter was induced by the
addition of isopropyl--D-thiogalactopyranoside to a final con-
centration of 1mM.Antibioticswere addedwhen appropriate at
the following concentrations: streptomycin, 100 g/ml; ampi-
cillin, 50 g/ml; kanamycin, 50 g/ml; chloramphenicol (Cm),
5 or 10 g/ml (for V. cholerae and E. coli, respectively).
Plasmid and Strain Construction—All strains and plasmids
used in this study are listed in Table 1. Plasmids with oriR6K
were propagated in DH5pir; all other plasmids were propa-
gated in DH5. For expression and purification of the V. chol-
erae PlzA, PlzB, PlzC, PlzD, and PlzE proteins, the correspond-
ing genes were amplified by PCR from V. cholerae O395
genomic DNA using oligonucleotide primers listed in Table 2.
Each forward primer includes an XbaI restriction site and a
strong ribosome binding site; each reverse primer contains an
SphI site. A His6 tag was introduced by including the appropri-
ate sequence in the indicated primer. PlzD and PlzE were
amplified to include an N-terminal His6 tag using primers
A042HF/C0042R and A735HF/C0735R, respectively. Simi-
larly, PlzA, PlzB, and PlzC were tagged with His6 at the C ter-
minus using primers C0697F/0697HR, C1885F/1885HR, and
C2344F/2344HR, respectively. PCR products were digested
with SphI and XbaI, ligated into similarly digested pBAD33,
and transformed into E. coli DH5. Correct clones were iden-
tified by PCR and/or digestion and by detection of the appro-
priate sized protein in cell extracts using anti-His5 antibodies
(Qiagen). The resulting strains (AC2210, AC2212, AC2213,
AC2214, and AC2216) are described in Table 1.
Point mutations that changed conserved residues in PlzD to
alanine were generated by splicing by overlapping extension
PCR (43), using pAC2210 as a template. Primers R1 and F2
containing the desired point mutation were used in combina-
tion with A0042HF and C0042R, respectively. PCR products
were annealed together by complementary sequences in R1 and
F2 primers and PCR-amplified using A0042HF and C0042R.
The final products were digested with XbaI/SphI and cloned
into similarly digested pBAD33. Primer pairs used were
R136R1/R136F2, R140R1/R140F2, D162R1/D162F2, S164R1/
S164F2, and G167R1/G167F2, with the number corresponding
to the amino acid altered.
Plasmids for generating in-frame deletions and point
mutations in V. cholerae were constructed in the allelic
exchange vector pCVD442, which encodes the sacB counter-
selectable marker (44). Splicing by overlapping extension
PCR was used to generate all deletions (43). DNA fragments
of 800 bp upstream and downstream of each deletion were
amplified by PCR from V. cholerae N16961 genomic DNA,
annealed together by complementary sequences in the R1
and F2 primers, and PCR-amplified with the F1 and R2 prim-
ers. The final PCR product was ligated into pCVD442 follow-
ing digestion with either XbaI (pJP2337, pJP2338, pJP2339,
and pJP2340) or XbaI/SacI (pJP2341). The respective F1/R1
and F2/R2 primer pairs used for generating deletion alleles of
plzA, plzB, plzC, plzD, and plzE products were 0697F1/
0697R1 and 0697F2/0697R2, 1885F1/1885R1 and 1885F2/
1885R2, 2344F1/2344R1 and 2344F2/2344R2, 0042F1/0042R1
and 0042F2/0042R2, and 0735F1/0735R1 and 0735F2/0735R2,
respectively. The F1/R1 and F2/R2 primer pairs used for gener-
ating the plzBR96A and plzDR140A point mutants were
1885F1/R96AR1 and 1885F2/R96AR2 and 0042F1/R140AR1
and R140AF2/0042R2, respectively.
V. cholerae strains AC2342, AC2344, and AC2346 contain-
ing in-frame deletions of plzB, plzD, and plzC, respectively, and
AC2458 containing the plzBR96A point mutation were gener-
ated by allelic exchange with plasmid pJP2339, pJP2340,
pJP2341, and pJP2460, respectively, in the wild-type (AC61)
background. Strains AC2343, AC2345, and AC2347 were gen-
erated by allelic exchange with plasmid pJP2339, pJP2340, and
pJP2341, respectively, in the O395 vieAE170A (AC1596) back-
ground. StrainAC2553, containing an in-framedeletion ofplzC
and the plzDR140 point mutation, was generated by allelic
exchange with plasmid pJP2555 in the plzC (AC2346) back-
ground. Plasmids were conjugated into AC61, AC1596, and
AC2346 from E. coli SM10pir as previously described (45).
After one passage in LB broth in the absence of antibiotics,
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sucrose-resistant colonies were selected andwere subsequently
screened for the desired deletion by PCR.
For complementation of PilZ mutant phenotypes, plzD,
plzA, plzE, plzB, and plzCwere PCR-amplified fromV. cholerae
O395 genomic DNA using the following primer pairs: C0042F/
C0042R, C0697F/C0697R, C0735F/C0735R, C1885F/C1885R,
andC2344F/C2344R, respectively (Table 1). The PCR products
were digestedwith SphI andXbaI and cloned into pMMB67EH.
Correct clones were identified by PCR and are listed in Table 2
(pAC2137-pAC2141). Complementation plasmids were intro-
duced intoV. cholerae by electroporation, and ampicillin-resis-
tant transformants were selected. The resulting strains
(AC2342 to AC2353, AC2459, AC2551, AC2552, and AC2554)
are described in Table 1.
Expression and Purification of PilZ Proteins and Controls—
The five V. cholerae PilZ proteins, five PlzD point mutation
derivatives, and CheY were overexpressed in and purified
from E. coli. Briefly, AC1173 (parent plasmid control),
AC2210, AC2212, AC2213, AC2214 ,AC2216, AC2402,
AC2403, AC2404, AC2405, and AC2406 were grown in LB
broth supplemented with Cm for 16 h at 37 °C with aeration.
The overnight cultures were diluted 1:200 in 200ml of fresh LB
plus Cm and incubated at 30 °C with aeration to midexponen-
tial phase (A600  0.45). L-Arabinose was added to induce
expression. AC1173, AC2069, AC2212, AC2213, AC2214, and
AC2216 were then grown at 30 °C for an additional 3 h.
AC2210, AC2402, AC2403, AC2404, AC2405, and AC2406
were shifted to 18 °C and grown for 5 hmore. TheCheY control
was similarly expressed in and purified from AC2069. Briefly,
an overnight culture of AC2069 was diluted 1:100 in LB plus
kanamycin; protein expression was induced with isopropyl--
D-thiogalactopyranoside followed by 3 h of further growth at
30 °C. Cells were pelleted, and His6-tagged PilZ proteins were
purified as described previously (17). The concentration of pro-
tein in the resulting preparations was measured using a modi-
fied Lowry protein assay kit (Pierce). Ten g of protein were
separated by SDS-PAGE on a 4–15%Tris-HCl precast gel (Bio-
Rad) and transferred to a nitrocellulose membrane. PilZ pro-
teins of the expected size were detected using mouse anti-His5
antibodies (Qiagen) and horseradish peroxidase-conjugated
sheep anti-mouse antibodies (Amersham Biosciences) (data
not shown).
c-di-GMPBindingAssays—Four separatemethodswere used
to detect binding of radiolabeled c-di-GMP to the PilZ proteins.
[32P]c-di-GMPwas synthesized enzymatically as described previ-
ouslyusingVCA0956 (17)orWspR(44)DGCs,whichworkequiv-
alently, and 0.33 M [-32P]GTP (PerkinElmer Life Sciences). In
the first method, binding was assayed after denaturing condi-
tions. Ten g of each PilZ protein, the CheY control, or mock-
purified vector control were separated by SDS-PAGE on a
4–15% Tris-HCl precast gel and transferred to a nitrocellulose
membrane. The membrane was incubated in phosphate-buff-
ered saline containing 1% skim milk for 0.5 h at room temper-
ature and then probed with 2 nM [32P]c-di-GMP for 2 h. After
three 5-min washes with phosphate-buffered saline, radiola-
beled bandswere visualized by phosphorimaging. In the second
method, binding was assayed under native conditions. Each
PilZ protein, the CheY control, ormock-purified vector control
were separated on a 4–15% Tris-HCl precast gel in the absence
of SDS or -mercaptoethanol, transferred to nitrocellulose
membranes, and probed with [32P]c-di-GMP as described
above. For the third method, 10 g of each PilZ protein, the
CheY control, or mock-purified vector control were spotted
directly onto nitrocellulose strips, allowed to dry for 0.5 h at
37 °C, and then probed with radiolabeled c-di-GMP as
described above. For the fourthmethod, binding was assayed in
solution. E. coli strains (AC2137, AC2138, AC2139, AC2140,
AC2141, andAC2046) orV. cholerae strains (AC1109, AC2143,
AC2144, AC2145, AC2146, and AC2147) were grown in LB
broth supplemented with Cm or ampicillin for 16 h at 37 °C
with aeration. The overnight cultures were diluted 1:200 in 200
ml of fresh LB plus Cm or ampicillin and incubated at 37 °C
with aeration to midexponential phase (A600  0.45). L-Arabi-
nose or isopropyl--D-thiogalactopyranoside was added to
induce expression, and cultures were then grown at 30 °C for an
additional 3 h. Cells were pelleted and resuspended in c-di-
GMP binding buffer (50 mM Tris, pH 7.5, 10 mM MgCl2, 5 mM
CaCl2, 5 mM KCl) (3) plus 10% glycerol. All subsequent steps
were carried out at 4 °C. The bacterial suspensions were lysed
by French press at 16,000 p.s.i and fractionated by centrifuga-
tion at 10,000  g for 30 min. The supernatant was removed,
and the protein concentrationwas determinedusing amodified
Lowry protein assay kit. Either 200 g of cell lysate or 10 g of
purified PilZ proteins were brought to a volume of 100 l with
c-di-GMP binding buffer and incubated on ice for 10 min with
5 nM [32P]c-di-GMP. Immediately following, 900 l of cold
binding buffer was added, and the total volume was added to
the barrel of a 3-ml syringe attached to a Swinnex filter holder
(Millipore) containing a 0.22-m nitrocellulose filter (Milli-
pore). The solution was passed through the filter over a period
of 10 s with consistent pressure. The filter was washed once
with 900 l of cold c-di-GMP binding buffer. Radioactivity
associated with the flow-through and filter was measured by
liquid scintillation counting.
To measure the KD of c-di-GMP binding by purified PlzC
and PlzD proteins, solution binding assays were done as
above over a 1–2000 nM range of ligand concentration and
using 0.25 g of protein. Nonlinear regression analysis of the
binding data was done using a one-site binding equation to
calculate the KD.
PlzC and PlzD were tested for specificity of c-di-GMP bind-
ing by spotting the proteins on nitrocellulose strips and probing
with 0.013 M [32P]c-di-GMP alone, combined with 0.7 M
cold c-di-GMP, or combined with 0.7 M cold GTP, using the
methods described above.
Motility Assays—Chemotaxis plates composed of either 1%
tryptone, 0.5% NaCl, and 0.3% agar or M9  NRES and 0.3%
agar were used to assess motility of V. cholerae strains. Strains
were streaked for single colonies on LB agar plus antibiotics and
incubated overnight at 30 °C. Single colonies were removed
with a toothpick, stabbed into the chemotaxis plate, and incu-
bated for 16 h at 30 °C.
Crystal Violet Staining of Biofilms—Strains were grown for
16 h in LB plus antibiotics, diluted 1:1000 into 0.5 ml of LB plus
antibiotics in new 13-mmdiameter borosilicate glass tubes, and
incubated at room temperature without aeration for 48 h. The
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medium was aspirated, and adherent biofilms were gently
washed three timeswith LB. Biofilmswere then stainedwith 0.5
mg/ml crystal violet for 5min and thenwashed extensively with
water. Bound crystal violet was solubilized with 1 ml of 100%
ethanol and quantified by absorbance at 570 nm. Each experi-
ment was performed in triplicate.
TABLE 1
Bacterial strains and plasmids used in this study
Strain or plasmid Relevant genotype Source/Reference
E. coli strains
DH5 F-(lacZYA-argF) U169 recA1 endA1 hsdR17 supE44 thi-1 gyrA96 relA1 Refs. 53 and 54
DH5pir F-(lacZYA-argF) U169 recA1 endA1 hsdR17 supE44 thi-1 gyrA96 relA1 ::pir Refs. 53 and 54
SM10pir thi recA thr leu tonA lacY supE RP4-2-Tc::Mu ::pir Laboratory strain
HCB137 DE3 This work
AC1173 E. coli DH5 pBAD33, Cmr This work
AC2069 E. coli HCB137 DE3 pSB102, Knr This work
AC2210 E. coli DH5 (pBAD33::His6-plzD), Cmr This work
AC2212 E. coli DH5 (pBAD33::plzC-His6), Cmr This work
AC2213 E. coli DH5 (pBAD33::plzA-His6), Cmr This work
AC2214 E. coli DH5 (pBAD33::plzB-His6), Cmr This work
AC2216 E. coli DH5 (pBAD33::His6-plzE), Cmr This work
AC2137 E. coli DH5 (pMMB67EH::plzD), Apr This work
AC2138 E. coli DH5 (pMMB67EH::plzA), Apr This work
AC2139 E. coli DH5 (pMMB67EH::plzE), Apr This work
AC2140 E. coli DH5 (pMMB67EH::plzB), Apr This work
AC2141 E. coli DH5 (pMMB67EH::plzC), Apr This work
AC2402 E. coli DH5 (pBAD33::His6-plzDR136A), Cmr This work
AC2403 E. coli DH5 (pBAD33::His6-plzDR140A), Cmr This work
AC2404 E. coli DH5 (pBAD33::His6-plzDD162A), Cmr This work
AC2405 E. coli DH5 (pBAD33::His6-plzDS164A), Cmr This work
AC2406 E. coli DH5 (pBAD33::His6-plzDG167A), Cmr This work
V, cholerae strains
O395 classical biotype, Smr Ref. 29
AC61 O395 lacZ::res-Tet-res, Smr, Tcr Ref. 55
AC744 O395toxR, Smr Ref. 56
AC1109 O395 pMMB67EH, Smr, Apr Ref. 13
AC1539 AC61flaA, Smr, Tcr Ref. 8
AC1596 AC61 vieAE170A, Smr, Tcr Ref. 8
AC1815 AC61 vieAE170A (pMMB67EH), Smr, Tcr, Apr Ref. 13
AC1820 AC1596 (pAT1817), Smr, Tcr, Apr Ref. 13
AC1869 AC61 vpsR::pGP704 , Smr, Tcr, Apr Ref. 8
AC2143 O395 (pAC2137), Smr, Apr This work
AC2144 O395 (pAC2138), Smr, Apr This work
AC2145 O395 (pAC2139), Smr, Apr This work
AC2146 O395 (pAC2140), Smr, Apr This work
AC2147 O395 (pAC2141), Smr, Apr This work
AC2342 AC61 plzB, Smr, Tcr This work
AC2343 AC1596  plzB, Smr, Tcr This work
AC2344 AC61 plzD, Smr, Tcr This work
AC2345 AC1596 plzD, Smr, Tcr This work
AC2346 AC61 plzC, Smr, Tcr This work
AC2347 AC1596 plzC, Smr, Tcr This work
AC2348 AC2342 (pAC2140), Smr, Tcr, Apr This work
AC2349 AC2343 (pAC2140), Smr, Tcr, Apr This work
AC2350 AC2344 (pAC2137), Smr, Tcr, Apr This work
AC2351 AC2345 (pAC2137), Smr, Tcr, Apr This work
AC2352 AC2346 (pAC2141), Smr, Tcr, Apr This work
AC2353 AC2347 (pAC2141), Smr, Tcr, Apr This work
AC2458 AC61 plzBR96A, Smr, Tcr This work
AC2459 AC2458 (pAC2140) ), Smr, Tcr, Apr This work
AC2550 AC2346 plzD, Smr, Tcr This work
AC2551 AC2346 plzD (pAC2141) Smr, Tcr, Apr This work
AC2552 AC2346 plzD (pAC2137) Smr, Tcr, Apr This work
AC2553 AC2346 plzDR140A Smr, Tcr This work
AC2554 AC2346 plzDR140A (pAC2137) Smr, Tcr, Apr This work
Plasmids
pBAD33 pACYC184 ori, araC ParaBAD, Cmr Ref. 57
pMMB67EH IncQ broad host range cloning vector, Apr Ref. 58
pAT1817 pMMB67EH::vieA, Apr Ref. 8
pAC2137 pMMB67EH::plzD, Apr This work
pAC2138 pMMB67EH::plzA, Apr This work
pAC2139 pMMB67EH::plzE, Apr This work
pAC2140 pMMB67EH::plzB, Apr This work
pAC2141 pMMB67EH::plzC, Apr This work
pAC2210 pBAD33::His6-plzD, Cmr This work
pCVD442 oriR6K mobRP4 sacB, Apr Ref. 42
pJP2337 pCVD442::plzE, Apr This work
pJP2338 pCVD442::plzA, Apr This work
pJP2339 pCVD442::plzB, Apr This work
pJP2340 pCVD442::plzD, Apr This work
pJP2341 pCVD442::plzC, Apr This work
pJP2460 pCVD442::plzBR96A, Apr This work
pSB102 pET28bhisTEV::cheY-3, KnR This work
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Cholera Toxin Quantitation—Strains were grown at 30 °C
with aeration overnight in M9  NRES. The final A600 was
determined, cells were pelleted by centrifugation, and the
supernatant was filter-sterilized (0.45 m polyvinylidene diflu-
oride filter). The concentration of CT in supernatants was
determined by a GM1 enzyme-linked immunosorbent assay
using polyclonal goat antiserum to the CT B subunit (List Bio-
labs) and anti-goat IgG conjugated to alkaline phosphatase
(Sigma) as described previously (47). Purified CT B subunit of
known concentration (List Biolabs) was used to generate a
standard curve for use in determining the amount of CT B
subunit in the samples.
In Vivo Competition Assays—Competition assays using the
infant mouse model of infection were performed essentially as
described (13). The wild-type and PilZ mutant strains were
grown overnight on LB agar plus antibiotics at 37 °C. For each
strain, 10 colonies were resuspended in 200 l of LB, and the
A600 was determined. The strains were mixed 1:1 and adjusted
to a final A600 of 0.001 (106 colony-forming units/ml). Five-
day-old CD-1 infant mice were anesthetized by isoflurane
(2.5%) inhalation and intragastrically inoculated with 50 l of
this mixture. In vitro competitions were performed in parallel
by inoculating 2 l of the mix into 1 ml of LB and incubating
overnight at 37 °C with aeration.
RESULTS
V. cholerae PilZ Domain Proteins PlzC and PlzD Specifically
Bind c-di-GMP—To test the hypothesis that proteins contain-
ing the PilZ domain serve as c-di-GMP-binding proteins, the
five V. cholerae proteins that possess this domain (35) were
overexpressed, purified, and assayed for binding to 32P-radio-
labeled c-di-GMP using both membrane and solution binding
methods detailed under “Experimental Procedures.” Each of
the PilZ proteins contains one PilZ domain, with the exception
of PlzC, which contains two PilZ domains. There are no
assigned functions for any of these proteins nor any other iden-
tifiable domains.
TABLE 2
Primers used in this study


















































a Restriction sites are underlined, and the His6 sequences are italicized.
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After native electrophoretic separation and immobilization
on a membrane, two PilZ domain proteins, PlzC and PlzD,
bound c-di-GMP (Fig. 1A). The remaining three PilZ proteins
as well as the negative controls (chemotaxis response regulator
CheY and vector alone mock-purified) were unable to bind
c-di-GMP. PlzC and PlzD also bound c-di-GMP after spotting
the purified proteins directly onto a nitrocellulose membrane
(Fig. 1B). When assayed for binding after denaturing electro-
phoretic separation, PlzC retained the ability to bind c-di-GMP,
whereas PlzD lost the ability to bind (Fig. 1C).
We also examined solution binding of PilZ proteins to c-di-
GMP using a filter binding assay.Whole cell lysates from E. coli
andV. cholerae strains overexpressing each of the PilZ proteins
aswell as purifiedHis6-taggedPilZ domain proteinswere tested
for binding of c-di-GMP. Consistent with the above results,
only lysates from strains overexpressing PlzC and PlzD and
purified PlzC and PlzD showed binding above background lev-
els (data not shown).
We determined the binding affinity of PlzC and PlzD using
the filter binding assay. Nonlinear regression analysis of c-di-
GMP binding by PlzC and PlzD revealed that the proteins have
similar affinities for c-di-GMP. The dissociation constants (KD)
for PlzC and PlzD were 314 and 293 nM, respectively.
To assess the specificity of PlzC and PlzD binding to c-di-
GMP, the two purified proteins were incubated with a mixture
of [32P]c-di-GMP and either excess cold competitor c-di-GMP
or excess cold GTP. A molar excess of cold GTP did not inter-
fere with [32P]c-di-GMP binding (Fig. 1D), whereas cold c-di-
GMP decreased binding of radiolabeled c-di-GMP by both
PlzC and PlzD to the indicated amounts. Amolar excess of cold
competitor also substantially decreased binding of [32P]c-di-
GMP by PlzC and PlzD in filter binding experiments (data not
shown). These results indicate that PlzD and PlzC bind c-di-
GMP specifically.
Conserved Residues in the PilZ Domain Are Required for
Binding of c-di-GMP—Multiple alignment of V. cholerae PilZ
domain protein sequences with the PilZ domain from G. xyli-
nus cellulose synthase (AscA1) revealed seven conserved resi-
dues clustered toward theN terminus of the domain, consistent
with the results of Amikam and Galperin (35) (Fig. 2A). These
residues fell into two categories, either highly conserved, where
the specific residue was found in six out of the seven PilZ
domains examined, or conserved, where a hydrophobic residue
was consistently found at a given position in all domains exam-
ined. Using the crystal structure of the PlzD dimer (Protein
Data Bank entry 1YLN),4 we examined the location of the
highly conserved residues (Arg136, Arg140, Asp162, Ser164, and
Gly167) and found that eachof these residues resides in close prox-
imity on the same face of the PilZ domain of eachmonomer, sug-
gesting that theymaybe important forc-di-GMPbinding (Fig.2B).
In order to determine if these residues are required for PlzD bind-
ing of c-di-GMP, we changed each to an alanine. The subsequent
mutants were purified in parallel with the wild-type PlzD and
tested for binding of c-di-GMP using the filter binding assay. All
five mutant proteins were stably expressed at levels equivalent to
thewild type (Fig. 2C). Ineachcase,mutationof ahighly conserved
residue abrogated binding of c-di-GMP (Fig. 2D).
PlzB, PlzC, and PlzD Regulate Motility in V. cholerae—In
order to investigate potential roles of V. cholerae PilZ proteins
in c-di-GMP-regulated processes, we attempted to make in-
frame deletions of each of the five genes in both the wild-type
4 R. Zhang, M. Zhou, S. Moyi, F. Collart, and A. Joachimiak, unpublished data.
FIGURE 1. Binding of radiolabeled c-di-GMP to purified V. cholerae PilZ
domain proteins. A–C, lanes 1–7, PlzD, PlzE, PlzA, PlzB, PlzC, CheY, and mock-
purified, respectively. A, after native electrophoretic separation conditions,
proteins were transferred to nitrocellulose and probed with [32P]c-di-GMP.
PlzD and PlzC bound c-di-GMP. B, to avoid potential protein denaturation
during transfer to nitrocellulose, the PilZ domain proteins and controls were
spotted directly onto nitrocellulose and probed. Again, PlzD and PlzC bound
c-di-GMP. C, after denaturing electrophoretic separation conditions, proteins
were transferred to nitrocellulose, renatured, and probed. Only PlzC bound
c-di-GMP. D, to test the specificity of PlzD and PlzC binding to c-di-GMP, pro-
teins spotted to nitrocellulose were probed with [32P]c-di-GMP alone, [32P]c-
di-GMP plus excess cold c-di-GMP, or [32P]c-di-GMP plus excess cold GTP, as
indicated to the right. Incubation with excess cold c-di-GMP dramatically
decreased the amount of binding to [32P]c-di-GMP, whereas incubation with
excess cold GTP did not, indicating that binding of c-di-GMP to PlzD and PlzC
is specific. The fractions of [32P]c-di-GMP bound in the presence of cold com-
petitor compared with that of c-di-GMP alone are shown below each lane.
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and vieAE170A backgrounds. The vieAE170A strain harbors a
point mutation in a conserved residue shown to be required for
PDEA activity, leading to an increased cellular concentration of
c-di-GMP (8, 17). We were successful in making deletions of
plzB, plzC, and plzD. Our results suggest that the other two PilZ
genes, plzA and plzE, are essential.
To test whether plzB, plzC, or plzD regulates motility in V.
cholerae, we assayed their motility in rich (tryptone-based) and
minimal (M9  NRES) media semisolid agar (chemotaxis)
plates for 16 h at 30 °C. As shown in Fig. 3A, deletion of plzB
reduces motility in tryptone-based chemotaxis media, whereas
deletion of plzC or plzD has no effect. The motility defect of
plzB was confirmed using phase-contrast microscopy (data
not shown), and this defect was fully complemented by the
addition of plzB on a low copy number plasmid (Fig. 3A). The
vieAE170A motility phenotype is consistent with our previous
report that increased intracellular c-di-GMP concentration
leads to a reduction in motility (48). However, there was no
restoration of motility in the vieAE170A background by any of
the three PilZ gene deletions (Fig. 3A).
To test whether the PilZ domain itself is involved in regula-
tion of motility, we assayed motility of a plzB point mutant in a
FIGURE 2. Conserved PilZ domain residues are required for c-di-GMP binding. A, multiple alignment of V. cholerae PilZ domains with the first 39 amino acid
residues from the AcsA1 PilZ domain using MAFFT (available on the World Wide Web at www.biophys.kyoto-u.ac.jp/katoh/programs/align/mafft/). V.
cholerae proteins are listed by their locus names, and AcsA1 represents the PilZ domain from cellulose synthase 1 from G. xylinus. Each of the two PilZ domains
of PlzC are included and labeled accordingly. Highly conserved residues, those present in six of seven PilZ domains, are marked with an asterisk at the top.
Conserved hydrophobic residues are marked with a filled circle. B, ribbon diagram of one monomer of the PlzD dimer showing the locations of highly conserved
residues targeted for mutation, Arg136, Arg140, Asp162, Ser164, and Gly167. C, Western blot of purified His6-tagged wild-type and point mutant PlzD proteins.
Protein purification and Western blots were performed as described under “Experimental Procedures.” D, binding of [32P]c-di-GMP by PlzD point mutants.
Binding of 10 g of each His6-tagged purified protein (CheY, PlzD, PlzDR136A, PlzDR140A, PlzDD162A, PlzDS164A, and PlzDG167A) to [
32P]c-di-GMP was
measured in solution as described under “Experimental Procedures.” The amount of [32P]c-di-GMP bound is shown relative to that bound by wild-type PlzD.
The mean and S.D. values from triplicate assays are shown.
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tryptone-based chemotaxis plate. A strain with a mutation in
one of the highly conserved arginine residues in PlzB (R96A)
had a reduced motility phenotype similar to that of plzB (Fig.
3B). PlzBR96A is stably expressed (data not shown), and the
motility defect was fully complemented by the addition of plzB
in trans (Fig. 3B).
Experiments using M9  NRES semisolid agar plates gave
slightly different results. As expected, plzB showed decreased
motility, but in this condition, plzC also showed a decrease in
motility (Fig. 3C). Each of these defects could be fully comple-
mented by the addition of the corresponding gene in trans (Fig.
3C). Therefore, PlzB and PlzC are positive regulators of motil-
ity. Again, deletion of plzD had no effect on motility, and no
changes in motility were observed for PilZ mutants in the
vieAE170A background (Fig. 3C and data not shown).
Because we were not able to delete two of the PilZ genes, V.
cholerae strains overexpressing each of the five PilZ proteins
were analyzed for potential phenotypes in both conditions.
Overexpression of each protein in either the wild-type or
vieAE170A background had no effect on motility in tryptone-
based chemotaxis plates (data not shown). However, overex-
pression of PilZ domain proteins in M9  NRES chemotaxis
plates gave different results. In the wild-type background, over-
expression of plzC led to a slight increase in motility compared
with wild-type, whereas overexpression of plzD had a negative
effect on motility (Fig. 3D). However, overexpression of
plzDR140A had the same negative effect on motility as overex-
pression of plzD (data not shown), suggesting that this effect is
not dependent on the ability to bind c-di-GMP and that PlzD
may have functions independent of c-di-GMP binding. These
data further support a role for PlzC as a positive regulator of
motility and suggest that PlzDmay act as a negative regulator of
motility in a c-di-GMP-independent manner. Overexpression
of plzA, plzB, and plzE had no effect on motility, and no effects
were observed in the vieAE170A background (Fig. 3D; data not
shown).
PilZ Proteins PlzB and PlzC Regulate V. cholerae Biofilm
Formation—We have previously reported that c-di-GMP reg-
ulates biofilm formation in V. cholerae (8). To identify whether
PilZ proteins play a role in this process, we measured biofilm
formation at the air-liquid interface of standing cultures by
crystal violet staining (Fig. 4). A strain with an insertion muta-
tion in vpsR (vpsR::pGP704), a positive regulator of vps genes
(49), was used as a control. Deletion of plzB or mutation of the
PlzB PilZ domain, plzBR96A, reduced biofilm formation com-
pared with wild type. Therefore, PlzB positively regulates bio-
film formation in a PilZ-dependent manner.
As has been described previously, the vieAE170A mutant
forms a more robust biofilm as a result of increased c-di-GMP
concentration (8) (Fig. 4). Deletion of plzB or plzC in the
vieAE170A background abrogated this effect, and the mutants
formed biofilms similar to wild type. In each case, the comple-
menting plasmid restored biofilm formation to parental strain
levels (Fig. 4). A similar result was seen using a plzB or plzC
strain overexpressing the DGC VCA0956 (data not shown).
Thus, PlzB and PlzC function as positive regulators of biofilm
formation when the cellular level of c-di-GMP is elevated.
plzD did not play a role in biofilm formation under the con-
ditions tested, since deletion of the gene had no effect on bio-
film formation (Fig. 4). In addition, overexpression of each of
the five PilZ domain proteins in either the wild-type or
vieAE170A background had no effect on biofilm formation.
FIGURE 3. PilZ protein PlzB regulates motility in V. cholerae. V. cholerae
strains were inoculated into chemotaxis plates and incubated at 30 °C for
16 h. A (tryptone-based chemotaxis plate), wild type (wt), AC61;
vieAE170A, AC1596; flaA, AC1539; plzB, AC2342; plzB (pPlzB)
(pAC2140), AC2348; plzD, AC2344; plzC, AC2346; vieAE170A plzB,
AC2343; vieAE170A plzD, AC2345; vieAE170A plzC, AC2347. B (tryptone-
based chemotaxis plate), wt, AC61; plzB, AC2342; plzBR96A, AC2458;
plzBR96A (pPlzB) (pAC2140), AC2459. Magnification is 3. C (M9  NRES
chemotaxis plate), wt, AC61; vieAE170A, AC1596; plzB, AC2342; plzB
(pPlzB) (pAC2140), AC2348; plzD, AC2344; plzC, AC2346; plzC (pPlzC)
(pAC2141), AC2347. D (M9  NRES chemotaxis plate plus 1 mM isopropyl-
-D-thiogalactopyranoside), wt (pMMB67EH), AC1109; vieAE170A
(pMMB67EH), wt (pPlzA) (pAC2138), AC2144; wt (pPlzB) (pAC2140),
AC2146; wt (pPlzC) (pAC2141), AC2147; wt (pPlzD) (pAC2137), AC2143; wt
(pPlzE) (pAC2139), AC2145.
FIGURE 4. Biofilm formation is regulated by V. cholerae PilZ protein PlzB.
V. cholerae strains were grown in LB broth standing cultures at room temper-
ature for 16 h, and adherent biofilms were stained with crystal violet. Staining
was quantified by solubilizing bound crystal violet in ethanol and measuring
the absorbance at 570 nm. The mean and S.D. values from triplicate cultures
are shown. wt, AC61; vieAE170A, AC1596; vpsR::pGP704, AC1869; plzB,
AC2342; plzBR96A, AC2458; plzB (pPlzB) (pAC2140), AC2348; plzBR96A
(pPlzB) (pAC2140), AC2459; vieAE170A plzB, AC2342; vieAE170A plzB (pPlzB)
(pAC2140), AC2349; plzC, AC2346, vieAE170A plzC, AC2347; vieAE170A
plzC (pPlzC) (pAC2141), AC2347; plzD, AC2344; vieAE170A plzD, AC2345.
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PilZ Proteins PlzB, PlzC, and PlzDAre Required for Intestinal
Colonization—It was previously shown that control of c-di-
GMP concentration by the PDEA VieA in the V. cholerae clas-
sical biotype is required for colonization of the infant mouse
small intestine (13). Therefore, we investigated whether indi-
vidual PilZ proteins were required for intestinal colonization.
To address this question, competition assays in mice were
performed. We found that deletion of plzB or mutation of a
conserved PilZ domain residue (R96A) resulted in a 10-fold
decrease in colonization (Fig. 5A). These colonization
defects were fully complemented by expression of plzB in
trans (Fig. 5A).
Single deletion of either plzC or plzD had no effect on colo-
nization, whereas deletion of both (plzCplzD) led to a 3-fold
colonization defect (Fig. 5B). This colonization defect could be
complemented by expression of eiher plzC or plzD in trans.
Additionally, mutation of residue Arg140 of PlzD, which was
shown to be required for c-di-GMP binding (Fig. 2C), in the
plzC background resulted in the same 3-fold attenuation as
plzC plzD, and this attenutation could be complemented by
the addition of plzD in trans (Fig. 5B). Thus, the PilZ domain of
PlzD plays a role in the colonization of the infant mouse small
intestine.
PlzB, PlzC, and PlzD Are Not Required for c-di-GMP-medi-
ated Regulation of Cholera Toxin Expression—We have previ-
ously shown that c-di-GMP regulates CT expression inV. chol-
eraeO395 and that VieA is required for this regulation (13). To
determine if PilZ proteins are involved in the c-di-GMP-medi-
ated regulation of CT expression, we measured CT expression
by enzyme-linked immunosorbent assay in supernatants from
overnight cultures grown under vir-
ulence gene-inducing conditions,
incubation at 30 °C in M9  NRES
(42). However, CT expression was
not altered by deletion of plzB, plzC,
or plzD in the wild-type or
vieAE170A backgrounds (data not
shown). Additionally, overexpres-
sion of each PilZ protein in thewild-
type or vieAE170A background
showed no effect on CT expression
under these conditions (data not
shown).
DISCUSSION
In this report, we experimentally
confirm the hypothesis of Amikam
and Galperin (35) by showing that a
subset of PilZ proteins fromV. chol-
erae specifically bind c-di-GMP.
Additionally, we show that muta-
tion of the PilZ genes plzB,plzC, and
plzD results in alterations in cellular
processes known to be regulated by
c-di-GMP, including motility, bio-
film formation, and virulence.
Together, these data are consistent
with a role for at least some PilZ
proteins as c-di-GMP-sensing proteins and regulators of
diverse processes in bacteria.
Binding of c-di-GMP by PilZ Proteins—To date, only three
PilZ domain proteins have been shown to bind c-di-GMP,
including cellulose synthase fromG. xylinus, YcgR from E. coli,
and PA4608 from P. aeruginosa (3, 39, 40). Here we show that
two V. cholerae PilZ proteins (PlzC and PlzD) present in cell
extracts, as well as purified, bind c-di-GMP specifically and
with submicromolar affinities. Additionally, we show that five
highly conserved amino acid residues in the PlzD PilZ domain
are required for binding of c-di-GMP. Each of these residues is
found in a patch on the same face of the PilZ domain, sug-
gesting that they may act to coordinate c-di-GMP. Thus, it is
likely that the PilZ domain functions in c-di-GMP binding,
as hypothesized by Amikam and Galperin (35).
Our observation that PlzC but not PlzD was able to bind
c-di-GMP after denaturation suggests that either the latter pro-
tein cannot refold properly under the conditions used or that it
requires dimer- or multimerization in order to bind c-di-GMP,
as suggested by the recently solved crystal structure of PlzD
(Protein Data Bank entry 1YLN).4 Our inability to show PlzA,
PlzB, and PlzE binding to c-di-GMPmay be explained by one or
more of the following: 1) their binding affinities are low relative
to PlzC andPlzD, and thus binding is undetectable by themeth-
ods used in this study; 2) these proteins do not bind c-di-GMP;
3) additional cellular components lost during the protein puri-
fication are required for their binding to c-di-GMP (i.e. their
PilZ domains are not sufficient for binding of c-di-GMP); or 4)
these proteins do not fold properly or achieve their correct qua-
ternary structure when overexpressed in and purified from
FIGURE 5. V. cholerae plzB and plzBR96A strains are attenuated for virulence. Competition assays were
performed using the infant mouse model of infection. A, strains plzB (AC2342), plzBR96A (AC2458), were
competed against wild-type O395 (AC50). Strains plzB (pPlzB (pAC2140)) (AC2348) and plzBR96A (pPlzB
(pAC2140)) (AC2459) were competed against O395 (pMMB67EH) (AC1109), which contained the empty vector.
B, strains plzC (AC2356), plzD (AC2344), plzC plzD (AC2550), and plzC plzDR140A (AC2553) were com-
peted against wild-type O395 (AC50). Strains plzC plzD (pPlzC (pAC2141)) (AC2551), plzC plzD (pPlzD
(pAC2137)) (AC2552), and plzC plzDR140A (pPlzD (pAC2137)) (AC2554) were competed against O395
(pMMB67EH) (AC1109). The competitive index is the ratio of mutant to wild-type bacteria recovered from the
small intestine corrected for the input ratio. Each data point represents the competitive index from an individ-
ual mouse; the gray bar represents the geometric mean. The plzB, plzBR96A, plzC plzD, and plzC
plzDR140A strains are significantly attenuated (p  0.01) by Student’s two-tailed t test.
c-di-GMP Regulation via PilZ Proteins
12868 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 282 • NUMBER 17 • APRIL 27, 2007
E. coli. We attempted to rule out some of these possibilities by
assaying c-di-GMP binding of PilZ proteins in E. coli and V.
cholerae lysates; however, wewere unable to observe binding by
PilZ proteins other than PlzC and PlzD. Further structural and
biochemical characterization of PilZ domain proteinsmay shed
light on which of these possibilities is correct. It is worth noting
that one of the PilZ proteins for which we did not detect c-di-
GMP binding (PlzB) also lacks a number of the conserved res-
idues required for c-di-GMP binding by PlzD (Fig. 2A). Never-
theless, the plzB mutant had the most profound phenotypes
observed in this study, and mutation of a conserved PilZ
domain residue (Arg96) mirrored the phenotypes of the dele-
tion mutant. Thus, it remains a possibility that this protein
binds c-di-GMP in vivo and/or interacts via its PilZ domain
with other c-di-GMP regulatory components.
PilZ-mediated Regulation of Motility—Previous results have
shown that c-di-GMP acts as a negative regulator of motility in
V. cholerae (48). Here we found that motility of plzB,
plzBR96A, and plzCmutants was reduced, showing an inter-
mediate phenotype between wild type and vieAE170A. Thus,
PlzB and PlzC are positive regulators of motility under growth
conditions that result in a low intracellular concentration of
c-di-GMP. c-di-GMP has been shown to regulate biofilm and
virulence genes at the transcriptional level, so it seems reason-
able that motility would be regulated in the same manner by
controlling transcription of flagellar biosynthesis genes. The
regulatory cascade controlling flagellar biosynthesis in V. chol-
erae has been well characterized, with multiple proteins having
been identified as transcriptional regulators within the hierar-
chy (50, 51). It is possible that c-di-GMP affects the expression
or activity of one of these regulators through PlzB and PlzC.
Additionally, we found that overexpression of PlzD resulted in
reduced motility in M9  NRES chemotaxis plates, suggesting
that PlzD acts as a negative regulator of motility in this condi-
tion. Surprisingly, this regulation was independent of c-di-
GMP binding, since overexpression of PlzDR140A gave the
same motility defect.
PilZ-mediated Regulation of Biofilm Formation—We have
previously shown that c-di-GMP regulates biofilm formation
by positively regulating the transcription of vpsR, a positive reg-
ulator of vps gene transcription (8, 49). Here we find that dele-
tion of plzB in both wild-type and vieAE170A backgrounds and
deletion of plzD in the vieAE170A background results in a
decrease in biofilm formation. Also,mutation of the highly con-
served PilZ domain residue Arg96 in plzB showed the same
decrease in biofilm formation asplzB. These data suggest that
PlzB and PlzD act as positive regulators of biofilm formation at
both low (PlzB) and high (PlzB and PlzC) c-di-GMP levels.
One contradictory finding of this work is that PlzB and PlzD
function as positive regulators of both motility and biofilm for-
mation, whereas c-di-GMP has an inverse effect on these two
processes, acting as a negative regulator of motility and a posi-
tive regulator of biofilm formation. This suggests that regula-
tion of these processes by c-di-GMP involves additional pro-
teins besides PlzB and PlzD. Further studies are under way to
understand how PlzB and PlzD regulate these processes.
Role of PilZ Proteins in Intestinal Colonization—Deletion of
plzB and mutation of the conserved PilZ domain residue Arg96
reduced colonization of the infant mouse small intestine by
10-fold. This intestinal colonization defect may be due to the
observed reduction in motility. It has previously been shown
that deletion of flrA or flrC, two major positive regulators of
flagellar biosynthesis, also results in an approximately 10-fold
attenuation in colonization (13, 52). However, at this point, we
cannot rule out the possibility that other PlzB-regulated factors
play a role in virulence.
Deletion of either plzC or plzD individually had no effect on
colonization, but deletion of both genes resulted in a 3-fold
defectincolonization.ThiscolonizationdefectwasPilZdomain-
dependent, since we observed a similar 3-fold colonization
defect for a plzC plzDR140A mutant strain. We did not
observe changes in any other phenotypes of the double mutant
compared with the single deletion strains; therefore, we are
unsure of the reason for the observed attenuation. We predict
that other processes that play a role in colonization are jointly
regulated by PlzC and PlzD in response to c-di-GMP concen-
tration during infection. Finally, our data suggest that PlzD has
both c-di-GMP-dependent and -independent functions;
PlzDR140A can function similar to the wild-type protein in
regulating motility in M9  NRES chemotaxis plates but does
not have wild-type function in the mouse model of infection.
CT Expression Is Not Regulated by PlzB, PlzD, or PlzC—We
have previously shown that c-di-GMP regulates CT expression
inV. cholerae (13). However, we did not observe changes in CT
expression in any of the PilZ mutant strains tested in the pres-
ent study. Nor did we observe changes in CT expression when
PilZ domain proteins were overexpressed. It is possible that
PlzB, PlzC, and PlzD perform redundant roles in regulation of
CT expression. Also, the PilZ proteinswewere unable to delete,
PlzA and PlzE, may be involved in regulation of CT. Further
study, perhaps involvingmultiple PilZ gene deletions, is needed
to determine what role if any PilZ proteins play in c-di-GMP-
mediated regulation of CT.
CONCLUSION
Based on our observations that PlzC and PlzD bind c-di-
GMP tightly and specifically via their PilZ domains and that
mutation of PlzB, PlzC, and PlzD causes changes in motility,
biofilm formation, and virulence in a PilZ domain-dependent
manner, it is tempting to speculate that, by analogy toG. xylinus
cellulose synthase, unknown output domains of PlzB, PlzC, and
PlzD are allosterically regulated by c-di-GMP binding. Such
binding may induce structural changes that regulate activity of
these hypothetical PlzB, PlzC, and PlzD output domains.
Future structural and biochemical studies of PlzB, PlzC, and
PlzD may shed light on this possibility.
We have previously proposed a model of c-di-GMP-medi-
ated regulation of V. cholerae biofilm formation, motility, and
virulence that includes factors downstream of c-di-GMP that
sense changes in intracellular c-di-GMP concentration and
relay this signal downstream, leading to changes in gene tran-
scription. Our data suggest that PilZ proteins represent this
factor. Additional work to characterize the role of individual
PilZ proteins within the c-di-GMP regulatory network is under
way andwill be needed to elucidate how these proteinsmediate
c-di-GMP-dependent regulation.
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